470 related articles for article (PubMed ID: 10604473)
1. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.
Bibb JA; Snyder GL; Nishi A; Yan Z; Meijer L; Fienberg AA; Tsai LH; Kwon YT; Girault JA; Czernik AJ; Huganir RL; Hemmings HC; Nairn AC; Greengard P
Nature; 1999 Dec; 402(6762):669-71. PubMed ID: 10604473
[TBL] [Abstract][Full Text] [Related]
2. Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin.
Desdouits F; Siciliano JC; Greengard P; Girault JA
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2682-5. PubMed ID: 7708705
[TBL] [Abstract][Full Text] [Related]
3. Amplification of dopaminergic signaling by a positive feedback loop.
Nishi A; Bibb JA; Snyder GL; Higashi H; Nairn AC; Greengard P
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12840-5. PubMed ID: 11050161
[TBL] [Abstract][Full Text] [Related]
4. Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A.
Nishi A; Bibb JA; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P
J Neurochem; 2002 May; 81(4):832-41. PubMed ID: 12065642
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling.
Nishi A; Liu F; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1322-7. PubMed ID: 12538871
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors.
Liu F; Ma XH; Ule J; Bibb JA; Nishi A; DeMaggio AJ; Yan Z; Nairn AC; Greengard P
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11062-8. PubMed ID: 11572969
[TBL] [Abstract][Full Text] [Related]
7. Identification of tyrosine hydroxylase as a physiological substrate for Cdk5.
Kansy JW; Daubner SC; Nishi A; Sotogaku N; Lloyd MD; Nguyen C; Lu L; Haycock JW; Hope BT; Fitzpatrick PF; Bibb JA
J Neurochem; 2004 Oct; 91(2):374-84. PubMed ID: 15447670
[TBL] [Abstract][Full Text] [Related]
8. D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade.
Flores-Hernandez J; Hernandez S; Snyder GL; Yan Z; Fienberg AA; Moss SJ; Greengard P; Surmeier DJ
J Neurophysiol; 2000 May; 83(5):2996-3004. PubMed ID: 10805695
[TBL] [Abstract][Full Text] [Related]
9. Repeated acetyl-l-carnitine administration increases phospho-Thr34 DARPP-32 levels and antagonizes cocaine-induced increase in Cdk5 and phospho-Thr75 DARPP-32 levels in rat striatum.
Scheggi S; Rauggi R; Nanni G; Tagliamonte A; Gambarana C
Eur J Neurosci; 2004 Mar; 19(6):1609-20. PubMed ID: 15066157
[TBL] [Abstract][Full Text] [Related]
10. Regulation of DARPP-32 Thr75 phosphorylation by neurotensin in neostriatal neurons: involvement of glutamate signalling.
Matsuyama S; Fukui R; Higashi H; Nishi A
Eur J Neurosci; 2003 Sep; 18(5):1247-53. PubMed ID: 12956723
[TBL] [Abstract][Full Text] [Related]
11. Dephosphorylation of Ser-137 in DARPP-32 by protein phosphatases 2A and 2C: different roles in vitro and in striatonigral neurons.
Desdouits F; Siciliano JC; Nairn AC; Greengard P; Girault JA
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):211-6. PubMed ID: 9461512
[TBL] [Abstract][Full Text] [Related]
12. The role of DARPP-32 in the actions of drugs of abuse.
Nairn AC; Svenningsson P; Nishi A; Fisone G; Girault JA; Greengard P
Neuropharmacology; 2004; 47 Suppl 1():14-23. PubMed ID: 15464122
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase I in vitro and in vivo.
Desdouits F; Cohen D; Nairn AC; Greengard P; Girault JA
J Biol Chem; 1995 Apr; 270(15):8772-8. PubMed ID: 7721783
[TBL] [Abstract][Full Text] [Related]
14. Glutamate Counteracts Dopamine/PKA Signaling via Dephosphorylation of DARPP-32 Ser-97 and Alteration of Its Cytonuclear Distribution.
Nishi A; Matamales M; Musante V; Valjent E; Kuroiwa M; Kitahara Y; Rebholz H; Greengard P; Girault JA; Nairn AC
J Biol Chem; 2017 Jan; 292(4):1462-1476. PubMed ID: 27998980
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II.
Girault JA; Hemmings HC; Williams KR; Nairn AC; Greengard P
J Biol Chem; 1989 Dec; 264(36):21748-59. PubMed ID: 2557337
[TBL] [Abstract][Full Text] [Related]
16. DARPP-32: an integrator of neurotransmission.
Svenningsson P; Nishi A; Fisone G; Girault JA; Nairn AC; Greengard P
Annu Rev Pharmacol Toxicol; 2004; 44():269-96. PubMed ID: 14744247
[TBL] [Abstract][Full Text] [Related]
17. ARPP-16 Is a Striatal-Enriched Inhibitor of Protein Phosphatase 2A Regulated by Microtubule-Associated Serine/Threonine Kinase 3 (Mast 3 Kinase).
Andrade EC; Musante V; Horiuchi A; Matsuzaki H; Brody AH; Wu T; Greengard P; Taylor JR; Nairn AC
J Neurosci; 2017 Mar; 37(10):2709-2722. PubMed ID: 28167675
[TBL] [Abstract][Full Text] [Related]
18. Regulation of spinophilin Ser94 phosphorylation in neostriatal neurons involves both DARPP-32-dependent and independent pathways.
Uematsu K; Futter M; Hsieh-Wilson LC; Higashi H; Maeda H; Nairn AC; Greengard P; Nishi A
J Neurochem; 2005 Dec; 95(6):1642-52. PubMed ID: 16300646
[TBL] [Abstract][Full Text] [Related]
19. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated neuronal phosphoprotein. II. Comparison of the kinetics of phosphorylation of DARPP-32 and phosphatase inhibitor 1.
Hemmings HC; Nairn AC; Greengard P
J Biol Chem; 1984 Dec; 259(23):14491-7. PubMed ID: 6501303
[TBL] [Abstract][Full Text] [Related]
20. Dopamine and cyclic AMP-regulated phosphoprotein-32 phosphorylation pattern in cocaine and morphine-sensitized rats.
Scheggi S; Rauggi R; Gambarana C; Tagliamonte A; De Montis MG
J Neurochem; 2004 Aug; 90(4):792-9. PubMed ID: 15287884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
